Organization · Venture Capital
R42 Group
R42 Group is a venture capital fund based in Stanford, California, focusing on early-stage investments in AI, deep science, and biotechnology. The firm supports entrepreneurs from the pre-seed stage through growth, leveraging a global network and expertise in science and strategic planning.
Overview
What R42 Group does
What R42 Group is
R42 Group is a venture capital fund based in Stanford, California, focusing on early-stage investments in AI, deep science, and biotechnology. The firm supports entrepreneurs from the pre-seed stage through growth, leveraging a global network and expertise in science and strategic planning.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find R42 Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
R42 Group as a funder
Investment thesis
R42 Group focuses on investments at the intersection of mathematics and medicine, emphasizing artificial intelligence, biotechnology, and longevity science.
Focus narrative
R42 Group invests in early-stage companies and funds that align with its values, particularly in the sectors of artificial intelligence, biotechnology, and deep science. The organization works with companies at various stages, from pre-seed to growth, and emphasizes collaboration with entrepreneurs to develop innovative solutions.
Value beyond capital
R42 Group provides not only capital but also strategic guidance and resources to its portfolio companies, leveraging the expertise of its team and advisors to foster innovation and growth.
Terms and economics
- Typical check
- $250,000–$5,800,000
- Sweet spot
- $5,820,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Regions
- United KingdomUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 70
- Recorded notable exits
- Motorola, BlackBerry, and Apple
Portfolio context
R42 Group has a diverse portfolio that includes notable companies and technologies such as Healx (AI-enabled biotech for rare diseases), Fountain Therapeutics (longevity), Rubedo Life Sciences (longevity), and AI Prostate Cancer Diagnostics (utilizing AI for improved diagnostics in prostate cancer).
Common questions
What to know about R42 Group
Upseed classifies R42 Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.